FAS Wealth Partners, Inc. - ACURA PHARMACEUTICALS INC ownership

ACURA PHARMACEUTICALS INC's ticker is ACUR and the CUSIP is 00509L703. A total of 34 filers reported holding ACURA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
FAS Wealth Partners, Inc. ownership history of ACURA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$81,000
+24.6%
81,9830.0%0.04%
+24.2%
Q1 2015$65,000
+75.7%
81,9830.0%0.03%
+65.0%
Q4 2014$37,000
-42.2%
81,9830.0%0.02%
-45.9%
Q3 2014$64,000
-28.1%
81,9830.0%0.04%
-27.5%
Q2 2014$89,000
-25.8%
81,9830.0%0.05%
-37.0%
Q1 2014$120,000
-22.1%
81,983
-10.9%
0.08%
-12.0%
Q4 2013$154,00091,9830.09%
Other shareholders
ACURA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 9,871,985$9,684,0001.75%
FAS Wealth Partners, Inc. 81,983$81,0000.04%
Lincoln Capital LLC 21,000$21,0000.02%
INTRUST BANK NA 23,960$24,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,384$239,0000.01%
Spark Investment Management LLC 35,200$34,0000.01%
CORTLAND ASSOCIATES INC/MO 21,550$21,0000.00%
Mariner, LLC 11,000$11,0000.00%
VANGUARD GROUP INC 980,433$967,0000.00%
THOMPSON DAVIS & CO., INC. 32$00.00%
View complete list of ACURA PHARMACEUTICALS INC shareholders